This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare
5 Safe Stocks to Counter IMF's Dull Global Economic Outlook
by Zacks Equity Research
Global economy is slowing down and IMF has turned pessimistic. This is the perfect time for investors to go defensive and invest in these five stocks.
Genesis Healthcare (GEN) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Genesis Healthcare (GEN) closed the most recent trading day at $1.52, making no change from the previous trading session.
The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet
Buy These 5 Defensive Stocks to Counter Market Volatility
by Zacks Equity Research
Markets have turned volatile due to poor economic data and geopolitical tensions, here are five defensive stocks to boost your portfolio.
Nursing Industry Outlook Buoyant on Increasing Life Expectancy
by Sapna Bagaria
Aging baby boomer population, need for low-cost care facilities and consolidation should aid the growth of the nursing industry.
Is Genesis Healthcare (GEN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (GEN) Outperforming Other Medical Stocks This Year?
Genesis Healthcare (GEN) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Genesis Healthcare (GEN) closed at $1.17, marking no change from the previous day.
Genesis Healthcare Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Genesis Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.
Genesis Healthcare (GEN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Genesis Healthcare (GEN) closed the most recent trading day at $1.19, moving +0.42% from the previous trading session.
How Genesis Healthcare (GEN) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Genesis Healthcare (GEN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Has Genesis Healthcare (GEN) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (GEN) Outperforming Other Medical Stocks This Year?
New Strong Buy Stocks for September 25th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
New Strong Buy Stocks for September 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Genesis Healthcare, Inc. (GEN) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Genesis Healthcare, Inc. (GEN).
New Strong Buy Stocks for September 16th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
Is Genesis Healthcare (GEN) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (GEN) Outperforming Other Medical Stocks This Year?
Top Ranked Momentum Stocks to Buy for September 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th
New Strong Buy Stocks for September 4th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Genesis Healthcare (GEN) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 61.54% and -0.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Genesis Healthcare (GEN) This Season?
by Zacks Equity Research
Genesis Healthcare's (GEN) Q2 earnings should benefit from a stable census and reimbursement environment, effective cost management, improvement in therapy and staffing businesses.
Will Genesis Healthcare (GEN) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Genesis Healthcare (GEN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Genesis Healthcare (GEN) closed at $1.16, marking a +0.87% move from the previous day.
Zacks.com featured highlights include: Guess, Party City, Shoe Carnival, Genesis and Restoration Robotics
by Zacks Equity Research
Zacks.com featured highlights include: Guess, Party City, Shoe Carnival, Genesis and Restoration Robotics
Is Genesis Healthcare (GEN) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (GEN) Outperforming Other Medical Stocks This Year?